These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 23791298)

  • 1. Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis.
    Szabó T; Scherbakov N; Sandek A; Kung T; von Haehling S; Lainscak M; Jankowska EA; Rudovich N; Anker SD; Frystyk J; Flyvbjerg A; Pfeiffer AF; Doehner W
    Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):50-6. PubMed ID: 23791298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.
    Doehner W; Pflaum CD; Rauchhaus M; Godsland IF; Egerer K; Cicoira M; Florea VG; Sharma R; Bolger AP; Coats AJ; Anker SD; Strasburger CJ
    Eur J Endocrinol; 2001 Dec; 145(6):727-35. PubMed ID: 11720897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study.
    Christensen HM; Kistorp C; Schou M; Keller N; Zerahn B; Frystyk J; Flyvbjerg A; Faber J
    Metabolism; 2014 Jan; 63(1):141-9. PubMed ID: 24140097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure.
    Doehner W; Rauchhaus M; Ponikowski P; Godsland IF; von Haehling S; Okonko DO; Leyva F; Proudler AJ; Coats AJ; Anker SD
    J Am Coll Cardiol; 2005 Sep; 46(6):1019-26. PubMed ID: 16168285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin is increased in cardiac cachexia irrespective of body mass index.
    Araújo JP; Lourenço P; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    Eur J Heart Fail; 2009 Jun; 11(6):567-72. PubMed ID: 19359328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wasting as independent risk factor for mortality in chronic heart failure.
    Anker SD; Ponikowski P; Varney S; Chua TP; Clark AL; Webb-Peploe KM; Harrington D; Kox WJ; Poole-Wilson PA; Coats AJ
    Lancet; 1997 Apr; 349(9058):1050-3. PubMed ID: 9107242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor-kappaB activity in peripheral blood mononuclear cells in cachectic and non-cachectic patients with chronic heart failure.
    Siednienko J; Jankowska EA; Banasiak W; Gorczyca WA; Ponikowski P
    Int J Cardiol; 2007 Nov; 122(2):111-6. PubMed ID: 17270295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide.
    McEntegart MB; Awede B; Petrie MC; Sattar N; Dunn FG; MacFarlane NG; McMurray JJ
    Eur Heart J; 2007 Apr; 28(7):829-35. PubMed ID: 17403719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.
    Suskin N; McKelvie RS; Burns RJ; Latini R; Pericak D; Probstfield J; Rouleau JL; Sigouin C; Solymoss CB; Tsuyuki R; White M; Yusuf S
    Eur Heart J; 2000 Aug; 21(16):1368-75. PubMed ID: 10952826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of cachexia on cardiorespiratory reflex control in chronic heart failure.
    Ponikowski P; Piepoli M; Chua TP; Banasiak W; Francis D; Anker SD; Coats AJ
    Eur Heart J; 1999 Nov; 20(22):1667-75. PubMed ID: 10543930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
    Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P
    Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal imbalance in relation to exercise intolerance and ventilatory inefficiency in chronic heart failure.
    Agapitou V; Dimopoulos S; Kapelios C; Karatzanos E; Manetos C; Georgantas A; Ntalianis A; Terrovitis J; Karga H; Nanas S
    J Heart Lung Transplant; 2013 Apr; 32(4):431-6. PubMed ID: 23402947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased catabolic activity in adipose tissue of patients with chronic heart failure.
    Szabó T; Postrach E; Mähler A; Kung T; Turhan G; von Haehling S; Anker SD; Boschmann M; Doehner W
    Eur J Heart Fail; 2013 Oct; 15(10):1131-7. PubMed ID: 23696611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated adiponectin levels in patients with chronic heart failure: an independent predictor of mortality or a marker of cardiac cachexia?
    Celik T; Yaman H
    Int J Cardiol; 2010 Oct; 144(2):319-20. PubMed ID: 19304331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow.
    Doehner W; Bunck AC; Rauchhaus M; von Haehling S; Brunkhorst FM; Cicoira M; Tschope C; Ponikowski P; Claus RA; Anker SD
    Eur Heart J; 2007 Apr; 28(7):821-8. PubMed ID: 17353227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum adiponectin, anemia and left ventricular dimensions in patients with cardiac cachexia.
    Bozcali E; Polat V; Akbulut H; Ferzeyn Yavuzkir M; Karaca I
    Cardiology; 2013; 126(4):207-13. PubMed ID: 24051989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF).
    Fülster S; Tacke M; Sandek A; Ebner N; Tschöpe C; Doehner W; Anker SD; von Haehling S
    Eur Heart J; 2013 Feb; 34(7):512-9. PubMed ID: 23178647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-blockers modify the prognostic value of adiponectin in chronic heart failure.
    Van Berendoncks AM; Beckers P; Hoymans VY; Possemiers N; Coenen S; Elseviers MM; Vrints CJ; Conraads VM
    Int J Cardiol; 2011 Aug; 150(3):296-300. PubMed ID: 20488568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.
    Doehner W; Rauchhaus M; Florea VG; Sharma R; Bolger AP; Davos CH; Coats AJ; Anker SD
    Am Heart J; 2001 May; 141(5):792-9. PubMed ID: 11320368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity.
    Davos CH; Doehner W; Rauchhaus M; Cicoira M; Francis DP; Coats AJ; Clark AL; Anker SD
    J Card Fail; 2003 Feb; 9(1):29-35. PubMed ID: 12612870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.